Edesa Biotech (NASDAQ:EDSA) reported quarterly earnings results on February 13, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $-0.28, beating the consensus estimate of $-0.38 by $0.10 per share. Revenue came in at , meeting the estimate of .
Edesa Biotech's stock moved following the earnings release. The stock currently trades at $1.02 with a market capitalization of $12.3M.